ONC

BeOne Medicines Ltd. American Depositary Shares
$287.92 -0.92%

Recent alerts on ONC

All signals →
Insider trade Sale by Riva Alessandro
5d ago
Insider trade Sale by Dugan Margaret
5d ago
Insider trade Sale by Sanders Corazon (Corsee) D.
5d ago
Insider trade Sale by Baker Brothers Life Sciences LP
5d ago
Insider trade Sale by Baker Bros. Advisors (GP) LLC
5d ago
Insider trade Sale by 667, L.P.
5d ago
Insider trade Sale by BAKER BROS. ADVISORS LP
5d ago
Insider trade Sale by BAKER FELIX
5d ago
Insider trade Sale by BAKER JULIAN
5d ago
News FDA Accepts Summit's Lung Cancer Drug Application, Review Underway
14d ago
News BeOne Medicines Stock Gains Momentum With Early-Stage Trial Success For Pretreated Lymphoma Patients
14d ago
News Why Summit Therapeutics Rocketed Double-Digits Today
14d ago
News BeiGene Discontinues Lung Cancer Drug Study After Interim Data Showed Limited Survival Benefit
14d ago
News China-Based Biotech BeiGene Scores FDA Approval For Tevimbra/Chemo Combo For Untreated Patients With Esophageal Cancer
14d ago
News Alibaba, Super Micro Computer And XPeng Are Among Top 10 Large Cap Gainers Last Week (Feb 17-Feb 21): Are The Others In Your Portfolio?
14d ago
Insider trade Sale by Lee Chan Henry (SVP, General Counsel)
17d ago
News BeOne wins FDA accelerated nod for Beqalzi in lymphoma
19d ago
News BeOne projects 2026 revenue of $6.3B-$6.5B as it raises guidance by $100M
26d ago
Insider trade Sale by Chan Henry Lee (SVP, General Counsel)
52d ago
News BeOne wins China approval for Amgen’s lung cancer drug Imdelltra
53d ago
News BeOne Medicines gains orphan drug status for liver cancer asset
70d ago
Insider trade Sale by Chan Henry Lee (SVP, General Counsel)
80d ago
Insider trade Sale by Chan Henry Lee (SVP, General Counsel)
104d ago
News BeOne CEO on Business Strategy, Biotech Outlook
138d ago
News Jazz boasts of first-line Ziihera data in gastroesophageal cancers
146d ago

Get push alerts for ONC

Add it to your watchlist in the app and receive every signal the moment it fires.

Download for iOS